siRNA, Anti-Human ACVR1, 2'-MOE(CAT#: SIRGT03052WQ-2MOE)
The product SIRGT03052WQ-2MOE is a type of small interfering RNA (siRNA) that targets ACVR1 gene and regulates the expression of gene. The siRNA interferes with the expression of ACVR1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
Specifications | |
---|---|
Modification | 2'-O-methoxyethyl (2'-MOE) |
Scale | 20/50/100/200 nmole |
NCBI RefSeq | NM_001105.4; NM_001111067.2; NM_001347663.1; NM_001347664.1; NM_001347665.1; NM_001347666.1; NM_001347667.1 |
Alternative Names | ACTRI; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI |
Related Diseases | Fibrodysplasia Ossificans Progressiva, Brain Stem Glioma |
Purification | HPLC |